(E)-Methyl 3-(2,3,4-trimethoxyphenyl)acrylate

Catalog No. :
ACPONK144
CAS No. :
116406-21-4
Molecular Formula :
C13H16O5
Molecular Weight :
252.27

IUPAC Name:methyl (E)-3-(2,3,4-trimethoxyphenyl)acrylate

(E)-Methyl 3-(2,3,4-trimethoxyphenyl)acrylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$140.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-Methyl 3-(2,3,4-trimethoxyphenyl)acrylate
IUPAC Namemethyl (E)-3-(2,3,4-trimethoxyphenyl)acrylate
MDL No.MFCD12034620
Molecular FormulaC13H16O5
Molecular Weight252.27
SMILESO=C(OC)/C=C/C1=CC=C(OC)C(OC)=C1OC
InChI KeyBDPRQDJNPJRLOB-SOFGYWHQSA-N
Synonym(E)-3-(2,3,4-trimethoxyphenyl)acrylic acid methyl ester;(E)-3-(2,3,4-trimethoxyphenyl)prop-2-enoic acid methyl ester;methyl (2E)-3-(2,3,4-trimethoxyphenyl)acrylate;methyl (E)-3-(2,3,4-trimethoxyphenyl)prop-2-enoate;MFCD12034620;2-Propenoic acid, 3-(2,3,4-trimethoxyphenyl)-, methyl ester, (2E)-;Methyl (2E)-3-(2,3,4-trimethoxyphenyl)-2-propenoate
CAS No.116406-21-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPONK144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFUIK307 route compound structure diagram
    ACFUIK3071067-74-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPONK144 route product structure diagram
    ACPONK144116406-21-4
Inquiry

2. ACPONK144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSAO480 route compound structure diagram
    ACCSAO48021204-67-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPONK144 route product structure diagram
    ACPONK144116406-21-4
Inquiry

Comments (0)